Literature DB >> 32408142

Traffic signaling: new functions of huntingtin and axonal transport in neurological disease.

Hélène Vitet1, Vicky Brandt1, Frédéric Saudou2.   

Abstract

Over the past twenty years there have been numerous advances in our understanding of Huntington's disease (HD) and other neurodegenerative proteopathies such as Alzheimer's disease and Parkinson's disease. In each case, disease-specific proteins are expressed and accumulate; what has been less clear is precisely what problems are caused by the accumulation. Recently we have begun to appreciate that increased protein levels or changes in the ratios of different isoforms affect the movement of molecules along the axon, thereby disrupting neuronal function. Huntingtin, the protein involved in HD, plays a special role in axonal transport, and very recent studies have found that its activity - and the movement of its cargoes - is altered not only in HD but in other neurological diseases. Here, we contextualize these studies and consider how modulating huntingtin activity could provide new avenues to therapy.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2020        PMID: 32408142     DOI: 10.1016/j.conb.2020.04.001

Source DB:  PubMed          Journal:  Curr Opin Neurobiol        ISSN: 0959-4388            Impact factor:   6.627


  11 in total

Review 1.  Mitochondrial Abnormalities and Synaptic Damage in Huntington's Disease: a Focus on Defective Mitophagy and Mitochondria-Targeted Therapeutics.

Authors:  Neha Sawant; Hallie Morton; Sudhir Kshirsagar; Arubala P Reddy; P Hemachandra Reddy
Journal:  Mol Neurobiol       Date:  2021-09-14       Impact factor: 5.590

2.  In Vivo Imaging of Axonal Organelle Transport in the Mouse Brain.

Authors:  Johannes Knabbe; Jil Protzmann; Thomas Kuner
Journal:  Methods Mol Biol       Date:  2022

3.  Dissection and Direct Imaging of Axonal Transport in Drosophila Segmental Nerves.

Authors:  William M Saxton; Angeline Lim; Inna Djagaeva
Journal:  Methods Mol Biol       Date:  2022

Review 4.  Molecular Pathophysiological Mechanisms in Huntington's Disease.

Authors:  Anamaria Jurcau
Journal:  Biomedicines       Date:  2022-06-17

5.  Calcineurin and huntingtin form a calcium-sensing machinery that directs neurotrophic signals to the nucleus.

Authors:  Chiara Scaramuzzino; Emeline C Cuoc; Patrick Pla; Sandrine Humbert; Frédéric Saudou
Journal:  Sci Adv       Date:  2022-01-05       Impact factor: 14.136

6.  Huntingtin structure is orchestrated by HAP40 and shows a polyglutamine expansion-specific interaction with exon 1.

Authors:  Rachel J Harding; Justin C Deme; Johannes F Hevler; Sem Tamara; Alexander Lemak; Jeffrey P Cantle; Magdalena M Szewczyk; Nola Begeja; Siobhan Goss; Xiaobing Zuo; Peter Loppnau; Alma Seitova; Ashley Hutchinson; Lixin Fan; Ray Truant; Matthieu Schapira; Jeffrey B Carroll; Albert J R Heck; Susan M Lea; Cheryl H Arrowsmith
Journal:  Commun Biol       Date:  2021-12-08

Review 7.  The Role of Axonal Transport in Glaucoma.

Authors:  Mariana Santana Dias; Xiaoyue Luo; Vinicius Toledo Ribas; Hilda Petrs-Silva; Jan Christoph Koch
Journal:  Int J Mol Sci       Date:  2022-04-01       Impact factor: 5.923

Review 8.  Altered Cholesterol Homeostasis in Huntington's Disease.

Authors:  Radhia Kacher; Coline Mounier; Jocelyne Caboche; Sandrine Betuing
Journal:  Front Aging Neurosci       Date:  2022-04-19       Impact factor: 5.750

9.  Inhibition Of Tau Protein Aggregation By a Chaperone-like β-Boswellic Acid Conjugated To Gold Nanoparticles.

Authors:  Masoumeh Gharb; Amideddin Nouralishahi; Ali Riazi; Gholamhossein Riazi
Journal:  ACS Omega       Date:  2022-08-18

Review 10.  When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer's and Huntington's Disease.

Authors:  Santosh R D'Mello
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.